









市场行情
/
股票
/
nasdaq-kmts
/

Kestra Medical Technologies Ltd

KMTS

27.520USD

-0.030-0.11%

收盘 12/24, 13:00（美东）报价延迟15分钟

1.42B总市值

亏损市盈率 TTM



Kestra Medical Technologies Ltd

27.520

-0.030-0.11%

概览公司财务分析

概览

公司

财务

分析

关于 Kestra Medical Technologies Ltd 公司

Kestra Medical Technologies, Ltd. is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intelligent and connected. The Company has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The Company's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.

Kestra Medical Technologies Ltd简介



公司代码KMTS

公司名称Kestra Medical Technologies Ltd

上市日期Mar 06, 2025

CEOWebster (Brian Daniel)

员工数量330

证券类型Ordinary Share

年结日Mar 06

公司地址3933 Lake Washington Blvd Ne

城市KIRKLAND

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编98033

电话14252798002

网址

公司代码KMTS

上市日期Mar 06, 2025

CEOWebster (Brian Daniel)

Kestra Medical Technologies Ltd公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Brian Webster

President, Chief Executive Officer, Founder, Director

309.34K

-22.19%

Ms. Traci S. Umberger

Chief Administrative Officer, General Counsel, Director

104.92K

-13.17%

Dr. Elizabeth Kwo, M.D.

Independent Director

21.82K

Mr. Vaseem Mahboob

Chief Financial Officer

14.84K

-59.79%

Mr. Conor Hanley

Independent Director

13.12K

Mr. Phillip D. Foshee, Jr.

Senior Vice President - Research & Development

Ms. Mary Katherine (Kay) Ladone

Independent Director

Mr. Maxwell Bikoff

Independent Director

Mr. Al Ford

Chief Commercial Officer

Ms. Debra Schotz

Senior Vice President - Marketing

名称

名称/职务

职务

持股

持股变动

Mr. Brian Webster

President, Chief Executive Officer, Founder, Director

309.34K

-22.19%

Ms. Traci S. Umberger

Chief Administrative Officer, General Counsel, Director

104.92K

-13.17%

Dr. Elizabeth Kwo, M.D.

Independent Director

21.82K

Mr. Vaseem Mahboob

Chief Financial Officer

14.84K

-59.79%

Mr. Conor Hanley

Independent Director

13.12K

Mr. Phillip D. Foshee, Jr.

Senior Vice President - Research & Development

收入明细

由于公司未披露，未能获取相关数据

由于公司未披露，未能获取相关数据

业务

地区

由于公司未披露，未能获取相关数据

股东统计

更新时间: 11月17日周一

持股股东

股东类型

持股股东

占比

Bain Capital Private Equity, LP

46.31%

Fidelity Management & Research Company LLC

7.45%

Endeavour Medtech Growth II LP

4.54%

Ally Bridge Group (HK) Limited

3.91%

T. Rowe Price Associates, Inc.

3.11%

其他

34.68%

持股股东

占比

Bain Capital Private Equity, LP

46.31%

Fidelity Management & Research Company LLC

7.45%

Endeavour Medtech Growth II LP

4.54%

Ally Bridge Group (HK) Limited

3.91%

T. Rowe Price Associates, Inc.

3.11%

其他

34.68%

股东类型

持股股东

占比

Private Equity

46.31%

Investment Advisor

21.46%

Investment Advisor/Hedge Fund

11.85%

Corporation

4.54%

Venture Capital

2.82%

Hedge Fund

1.97%

Individual Investor

0.99%

Research Firm

0.20%

Bank and Trust

0.03%

其他

9.84%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

138

48.47M

94.21%

+1.86M

2025Q2

49.39M

96.22%

+48.70M

2025Q1

47.97M

93.41%

+47.97M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Bain Capital Private Equity, LP

27.02M

52.52%

Jun 30, 2025

Fidelity Management & Research Company LLC

2.84M

5.52%

+531.65K

+23.05%

Jun 30, 2025

Endeavour Medtech Growth II LP

2.65M

5.14%

+2.65M

Mar 31, 2025

Ally Bridge Group (HK) Limited

2.28M

4.44%

Jun 30, 2025

T. Rowe Price Associates, Inc.

990.60K

1.93%

+141.18K

+16.62%

Jun 30, 2025

Omega Fund Management, LLC

1.65M

3.2%

-150.00K

-8.35%

Jun 30, 2025

AllianceBernstein L.P.

1.31M

2.55%

+128.31K

+10.84%

Jun 30, 2025

Brown Advisory

580.02K

1.13%

+29.61K

+5.38%

Jun 30, 2025

Eventide Asset Management, LLC

1.06M

2.06%

+785.56K

+285.66%

Jun 30, 2025

Fidelity Institutional Asset Management

857.25K

1.67%

-35.40K

-3.97%

Jun 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

Global X HealthTech ETF

0.43%

Goldman Sachs Innovate Equity ETF

0.13%

Fidelity Blue Chip Growth ETF

0.06%

JPMorgan BetaBuilders US Small Cap Equity ETF

0.04%

iShares Russell 2000 Growth ETF

0.02%

Fidelity Nasdaq Composite Index ETF

0.01%

Global X Russell 2000 ETF

0.01%

Schwab U.S. Small-Cap ETF

0.01%

iShares Russell 2000 ETF

0.01%

iShares Morningstar Small-Cap ETF

0.01%

Global X HealthTech ETF

占比0.43%

Goldman Sachs Innovate Equity ETF

占比0.13%

Fidelity Blue Chip Growth ETF

占比0.06%

JPMorgan BetaBuilders US Small Cap Equity ETF

占比0.04%

iShares Russell 2000 Growth ETF

占比0.02%

Fidelity Nasdaq Composite Index ETF

占比0.01%

Global X Russell 2000 ETF

占比0.01%

Schwab U.S. Small-Cap ETF

占比0.01%

iShares Russell 2000 ETF

占比0.01%

iShares Morningstar Small-Cap ETF

占比0.01%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

Kestra Medical Technologies Ltd的前五大股东是谁？



Kestra Medical Technologies Ltd 的前五大股东如下：
Bain Capital Private Equity, LP持有股份：27.02M，占总股份比例：52.52%。
Fidelity Management & Research Company LLC持有股份：2.84M，占总股份比例：5.52%。
Endeavour Medtech Growth II LP持有股份：2.65M，占总股份比例：5.14%。
Ally Bridge Group (HK) Limited持有股份：2.28M，占总股份比例：4.44%。
T. Rowe Price Associates, Inc.持有股份：990.60K，占总股份比例：1.93%。

Kestra Medical Technologies Ltd的前三大股东类型是什么？



Kestra Medical Technologies Ltd 的前三大股东类型分别是：
Bain Capital Private Equity, LP
Fidelity Management & Research Company LLC
Endeavour Medtech Growth II LP